MARKET PRICE INFORMATION Sample Clauses

MARKET PRICE INFORMATION. The Cabot common stock is listed on the NYSE under the symbol “COG.” The Cimarex common stock is listed on the NYSE under the symbol “XEC.” The high and low trading prices for the Cabot common stock on May 21, 2021, the last trading day immediately before the public announcement of the merger, were $18.14 and $17.76, respectively. The high and low trading prices for the Cimarex common stock on May 21, 2021, the last trading day immediately before the public announcement of the merger, were $73.06 and $71.07, respectively. As of August 19, 2021, the last date before the date of this joint proxy statement/prospectus for which it was practicable to obtain this information, there were 399,664,181 shares of Cabot common stock outstanding and 102,826,592 shares of Cimarex common stock outstanding. Because the exchange ratio will not be adjusted for changes in the market price of either Cabot common stock or Cimarex common stock, the market value of Cabot common stock that Cimarex stockholders will have the right to receive on the date the merger is completed may vary significantly from the market value of the Cabot common stock that Cimarex stockholders would receive if the merger were completed on the date of this joint proxy statement/prospectus. As a result, you should obtain recent market prices of Cabot common stock and Cimarex common stock prior to voting your shares. For additional information, see the section entitled “Risk Factors” beginning on page 42. The following table sets forth the closing sale price per share of Cabot common stock as reported on the NYSE and the closing sale price per share of Cimarex common stock as reported on the NYSE, in each case on May 21, 2021, the last trading day before the public announcement of the parties entering into the merger agreement, and on August 19, 2021, the last practicable trading day prior to the mailing of this joint proxy statement/prospectus. The table also shows the estimated implied value of the merger consideration proposed for each share of Cimarex common stock as of the same two dates. The implied value was calculated by multiplying the NYSE closing price of a share of Cabot common stock on the relevant date by the exchange ratio of 4.0146 shares of Cabot common stock for each share of Cimarex common stock. Cabot Common Stock Closing Price Cimarex Common Stock Closing Price Exchange Ratio Implied Per Share Value of Merger Consideration May 21, 2021 $17.81 $71.19 4.0146 $ 71.50 August 19, 2021 $14....
Sample 1
AutoNDA by SimpleDocs
MARKET PRICE INFORMATION. 71 CAPITALISATION AND INDEBTEDNESS . . ....... ........ ....... ........ ....... .... 73
Sample 1
MARKET PRICE INFORMATION. The Shares have been listed on the Hong Kong Stock Exchange (Code: 2186) since 9 July 2014. Prior to that time, the Company’s Shares were listed on the main board of the Singapore Exchange Securities Trading Limited, or SGX-ST between the period from 5 May 2004 to 29 November 2012. The table below sets forth, for the periods indicated, the high and low closing prices per Share, as reported on the Hong Kong Stock Exchange: Closing Share Price Average daily Period High Low (HK$) trading volume (number of Shares in millions) 2015 First quarter ended 31 March 2015 . . . . . . . . . . . . . 9.60 8.40 6.1 Second quarter ended 30 June 2015 . . . . . . . . . . . . . 11.2 7.69 19.6 Third quarter ended 30 September 2015 . . . . . . . . . . 8.20 6.42 6.2 Fourth quarter ended 31 December 2015. . . . . . . . . . 2016 8.28 6.64 5.9 First quarter ended 31 March 2016 . . . . . . . . . . . . . 8.11 5.45 7.3 Second quarter ended 30 June 2016 . . . . . . . . . . . . . 5.81 4.47 11.8 Third quarter ended 30 September 2016 . . . . . . . . . . 5.47 4.51 6.1 Fourth quarter ended 31 December 2016. . . . . . . . . . 2017 5.59 4.41 12.5 First quarter ended 31 March 2017 . . . . . . . . . . . . . 5.16 4.56 16.7 Second quarter ended 30 June 2017 . . . . . . . . . . . . . 4.92 4.17 10.5 Third quarter ended 30 September 2017 . . . . . . . . . . 4.63 3.96 12.1 Fourth quarter ended 31 December 2017. . . . . . . . . . 2018 6.26 4.57 19.1 First quarter ended 31 March 2018 . . . . . . . . . . . . . 7.94 6.10 24.3 Second quarter ended 30 June 2018 . . . . . . . . . . . . . 9.69 7.68 31.6 Third quarter ended 30 September 2018 . . . . . . . . . . 8.80 6.33 19.4 Fourth quarter ended 31 December 2018. . . . . . . . . . 2019 6.85 5.07 9.5 First quarter ended 31 March 2019 . . . . . . . . . . . . . 6.86 5.01 13.3 Second quarter ended 30 June 2019 . . . . . . . . . . . . . 7.64 5.40 13.2 Third quarter ended 30 September 2019 . . . . . . . . . . 6.38 5.38 10.8 Fourth quarter ended 31 December 2019. . . . . . . . . . 2020 6.78 5.56 13.2 First quarter ended 31 March 2020 . . . . . . . . . . . . . 6.23 3.78 21.2 Second quarter ended 30 June 2020 . . . . . . . . . . . . . 5.23 3.54 23.4 Third quarter ended 30 September 2020 . . . . . . . . . . 5.17 4.2 16.4 Fourth quarter ended 31 December 2020. . . . . . . . . . 2021 4.82 3.59 13.6 First quarter ended 31 March 2021 . . . . . . . . . . . . . 6.5 3.58 43.3 Second quarter ended 30 June 2021 . . . . . . . . . . . . . 5.65 4.52 19.2 Third quarter ended 30 Se...
Sample 1

Related to MARKET PRICE INFORMATION

  • zone Information Publication ICANN’s publication of root-zone contact information for the TLD will include Registry Operator and its administrative and technical contacts. Any request to modify the contact information for the Registry Operator must be made in the format specified from time to time by ICANN at xxxx://xxx.xxxx.xxx/domains/root/.

  • Service Information Service Visit Date Mode of service Face-to face, telephone, etc. Responsibility for payment Used to exclude federal govt., WCB, etc. Main and secondary diagnoses ICD10-CA codes Main and other interventions and attributes CCI procedure codes and attributes Type of Anesthetic Identifies the type used for interventions (general, spinal, local, etc.) Provider types NACRS code assigned to provider type (MD, Dentist, RN, etc.) Doctor name and identifier Physician specific information Admit via Ambulance Used if a Client is brought to the service delivery site by ambulance Institution from and institution to Used when a Client is transferred from or to another acute care facility Visit disposition Discharged, admitted, left without being seen, etc. Schedule “D” Appendix 2 Additional Elements Required for Data Management (XXX) Client Identifying Information Province Client‟s Home Province AB, BC, SK, MB, NL, PE, NS, NB, QC, ON, NT, YT, NU, US, OC (Other Country), NR (Unsp. Non-resident) Service Information Facility Code AHS provided code that indicates service being provided. Facility Fee Dollar value of service being provided Alberta Health Physician Fee Billing Code Alberta Health Physician Service Fee code that further defines facility code Regional standard format and submission method remains as is via excel file and email. NOTE: Submission method may be adjusted in accordance with security standards of AHS. Schedule “D” Appendix 3

  • Notice Information Notices will be sent: If to LESSOR: INTERNATIONAL LEASE FINANCE CORPORATION 1999 Avenue of the Stars, 00xx Xxxxx Xxx Xxxxxxx, Xxxxxxxxxx 00000, X.X.X. Attention: Legal Department Fax: 000-000-0000 Telephone: 000-000-0000 If to LESSEE: AMERICAN TRANS AIR, INC. 0000 Xxxx Xxxxxxxxxx Xxxxxx Indianapolis International Airport Xxxxxxxxxxxx, Xxxxxxx 00000 Xxxxxx Xxxxxx of America Attention: Xxx Xxxxx Executive Vice President and Chief Financial Officer Fax: 000-000-0000 Telephone: 000-000-0000 or to such other places and numbers as either party directs in writing to the other party.

  • Root-­‐zone Information Publication ICANN’s publication of root-­‐zone contact information for the TLD will include Registry Operator and its administrative and technical contacts. Any request to modify the contact information for the Registry Operator must be made in the format specified from time to time by ICANN at xxxx://xxx.xxxx.xxx/domains/root/.

  • Disclosure Information The disclosure of information as to the names and addresses of the Holders of Trust Securities in accordance with Section 312 of the Trust Indenture Act, regardless of the source from which such information was derived, shall not be deemed to be a violation of any existing law or any law hereafter enacted which does not specifically refer to Section 312 of the Trust Indenture Act, nor shall the Property Trustee be held accountable by reason of mailing any material pursuant to a request made under Section 312(b) of the Trust Indenture Act.

  • False Information The Borrower or any Obligor has given the Bank false or misleading information or representations.

  • Current Information (a) During the period from the date of this Agreement to the Closing, each Party hereto shall promptly notify each other Party of any (i) significant change in its ordinary course of business, (ii) proceeding (or communications indicating that the same may be contemplated), or the institution or threat or settlement of proceedings, in each case involving the Parties the outcome of which, if adversely determined, could reasonably be expected to have a material adverse effect on the Party, taken as a whole or (iii) event which such Party reasonably believes could be expected to have a material adverse effect on the ability of any party hereto to consummate the Share Exchange.

  • More Information For more specific information about the terms and conditions of the ICA or DCA program, please see the ICA Disclosure Booklet or DCA Disclosure Booklet (as applicable) available from IAR or on xxx.xxxxxxxxxxxx.xxx.xxx/xxxxxxxxxxx.

  • Market Information Exchange and Xxxxxxxxxx brochures and research are often provided as trading tools. In addition, a CTS Platform may also contain certain market information. Customer acknowledges that: (a) any information Xxxxxxxxxx’x research department may communicate to Customer does not constitute an offer to sell or a solicitation of any offer to buy any Contract; (b) such recommendations and information, although based upon information obtained from sources believed by Xxxxxxxxxx to be reliable, are incidental to Xxxxxxxxxx’x business as a futures commission merchant, may be incomplete and not subject to verification, and will not serve as the primary basis for any decision by Customer; (c) Xxxxxxxxxx makes no representation, warranty, or guarantee as to, and shall not be responsible for, the accuracy or completeness of any information or trading recommendation furnished to Customer; (d) recommendations to Customer as to any particular transaction at any given time may differ among Xxxxxxxxxx’x personnel due to diversity in analysis of fundamental and technical factors and may vary from any standard recommendation made by Xxxxxxxxxx in its market letters or otherwise; and (e) Xxxxxxxxxx has no obligation or responsibility to update any market recommendations or information it communicates to Customer. Customer understands that Xxxxxxxxxx and its officers, directors, affiliates, stockholders, representatives, or associated persons may have positions in and may intend to buy or sell Contracts which are the subject of market recommendations furnished to Customer, and that the market positions of Xxxxxxxxxx or any such officer, director, affiliate, stockholder, representative, or associated person may or may not be consistent with the recommendations furnished to Customer by Xxxxxxxxxx.

  • Available Information The Company is subject to the periodic reporting requirements of the Exchange Act and, accordingly, is required to file or furnish certain reports with the Commission. These reports can be retrieved from the Commission's website (wxx.xxx.xxx) and can be inspected and copied at the public reference facilities maintained by the Commission located (as of the date of the Deposit Agreement) at 100 X Xxxxxx, X.X., Xxxxxxxxxx X.X. 00000.

Time is Money Join Law Insider Premium to draft better contracts faster.